MA28109A1 - Antagonistes du recepteur acetylcholine muscarinique - Google Patents

Antagonistes du recepteur acetylcholine muscarinique

Info

Publication number
MA28109A1
MA28109A1 MA28963A MA28963A MA28109A1 MA 28109 A1 MA28109 A1 MA 28109A1 MA 28963 A MA28963 A MA 28963A MA 28963 A MA28963 A MA 28963A MA 28109 A1 MA28109 A1 MA 28109A1
Authority
MA
Morocco
Prior art keywords
antagonists
muscarinic receptor
acetylcholine muscarinic
acetylcholine
receptor
Prior art date
Application number
MA28963A
Other languages
English (en)
Inventor
Michael R Palovich
Zehong Wan
Chongjie Zhu
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA28109A1 publication Critical patent/MA28109A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

ANTAGONISTES DU RECEPTEUR D'ACETYLCHOLINE MUSCARINIQUE Des antagonistes du récepteur d'acétylcholine muscarinique et des méthodes pour leur utilisation sont proposés.
MA28963A 2003-10-17 2006-04-25 Antagonistes du recepteur acetylcholine muscarinique MA28109A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51216103P 2003-10-17 2003-10-17

Publications (1)

Publication Number Publication Date
MA28109A1 true MA28109A1 (fr) 2006-08-01

Family

ID=34465319

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28963A MA28109A1 (fr) 2003-10-17 2006-04-25 Antagonistes du recepteur acetylcholine muscarinique

Country Status (22)

Country Link
US (1) US7507747B2 (fr)
EP (1) EP1677796A4 (fr)
JP (1) JP2007509061A (fr)
CN (1) CN1897947A (fr)
AP (1) AP2006003575A0 (fr)
AR (1) AR046114A1 (fr)
AU (1) AU2004281167A1 (fr)
BR (1) BRPI0415281A (fr)
CA (1) CA2542636A1 (fr)
EA (1) EA200600787A1 (fr)
EC (1) ECSP066486A (fr)
IL (1) IL174846A0 (fr)
IS (1) IS8440A (fr)
MA (1) MA28109A1 (fr)
MX (1) MXPA06004242A (fr)
NO (1) NO20062071L (fr)
OA (1) OA13270A (fr)
PE (1) PE20050442A1 (fr)
TW (1) TW200528448A (fr)
UY (1) UY28567A1 (fr)
WO (1) WO2005037224A2 (fr)
ZA (1) ZA200602783B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050250A1 (es) * 2003-07-17 2005-04-08 Glaxo Group Ltd Antagonistas de los receptores muscarinicos de la acetilcolina
AR046225A1 (es) * 2003-11-04 2005-11-30 Glaxo Group Ltd Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
WO2005087236A1 (fr) * 2004-03-11 2005-09-22 Glaxo Group Limited Nouveaux antagonistes du recepteur de l'acetylcholine muscarinique m3
JP2007529511A (ja) * 2004-03-17 2007-10-25 グラクソ　グループ　リミテッド Ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
WO2005095407A1 (fr) * 2004-03-17 2005-10-13 Glaxo Group Limited Antagonistes du recepteur d'acetylcholine muscarinique m3
MY144753A (en) 2004-04-27 2011-10-31 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
WO2005112644A2 (fr) * 2004-05-13 2005-12-01 Glaxo Group Limited Antagonistes récepteurs d'acétyle choline muscarinique
EP1957075A4 (fr) * 2004-11-15 2009-11-18 Glaxo Group Ltd Nouveaux antagonistes des recepteurs muscariniques de type m3 de l'acetylcholine
US20080275079A1 (en) * 2005-08-02 2008-11-06 Glaxo Group Limited M3 Muscarinic Acetylcholine Receptor Antagonists
WO2007022351A2 (fr) * 2005-08-18 2007-02-22 Glaxo Group Limited Antagonistes de recepteurs d'acetylcholine muscarinique
UY31636A1 (es) 2008-02-06 2009-08-03 Farmacoforos duales-antagonistas muscarinicos de pde4
PE20091553A1 (es) 2008-02-06 2009-10-30 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
TW201000476A (en) 2008-02-06 2010-01-01 Glaxo Group Ltd Dual pharmacophores-PDE4-muscarinic antagonistics
WO2010094643A1 (fr) 2009-02-17 2010-08-26 Glaxo Group Limited Dérivés de quinoline et applications associées dans la rhinite et l'urticaire

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800478A (en) 1955-07-01 1957-07-23 Smith Kline French Lab 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800481A (en) 1955-07-01 1957-07-23 Smith Kline French Lab Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
AT298118B (de) 1967-06-08 1972-04-25 Siemens Ag Verfahren zur Umsetzung von Spannungen in digitale Werte und Vorrichtung zur Durchführung des Verfahrens
GB2064336B (en) 1979-12-06 1984-03-14 Glaxo Group Ltd Device for dispensing medicaments
ATE23272T1 (de) 1981-07-08 1986-11-15 Draco Ab Pulverinhalator.
GB2169265B (en) 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
ZW21483A1 (en) 1982-10-08 1985-05-08 Glaxo Group Ltd Device for administering medicaments to patients
CH667657A5 (de) * 1985-01-07 1988-10-31 Sandoz Ag Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine.
NO166268C (no) 1985-07-30 1991-07-03 Glaxo Group Ltd Innretning for administrering av medikamenter til pasienter.
IT1204826B (it) 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
US5780466A (en) 1995-01-30 1998-07-14 Sanofi Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
AU5790598A (en) 1996-12-02 1998-06-29 Georgetown University Tropane derivatives and method for their synthesis
US6248752B1 (en) 1998-02-27 2001-06-19 Charles Duane Smith Azabicyclooctane compositions and methods for enhancing chemotherapy
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
CN1426411A (zh) * 2000-03-03 2003-06-25 奥索-麦克尼尔药品公司 3－(二芳基亚甲基)－8－氮杂双环[3.2.1]辛烷衍生物
WO2003033495A1 (fr) 2001-10-17 2003-04-24 Ucb, S.A. Derives de quinuclidine, leurs procedes de preparation, et leurs utilisations en tant qu'inhibiteurs de recepteur muscarinique m2 et/ou m3
US6696462B2 (en) 2002-01-31 2004-02-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
TW200410951A (en) 2002-08-06 2004-07-01 Glaxo Group Ltd M3 muscarinic acetylcholine receptor antagonists
WO2004091482A2 (fr) 2003-04-07 2004-10-28 Glaxo Group Limited Antagonistes du recepteur muscarinique m3 de l'acetylcholine
TW200523261A (en) 2003-07-17 2005-07-16 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
PE20050250A1 (es) 2003-07-17 2005-04-08 Glaxo Group Ltd Antagonistas de los receptores muscarinicos de la acetilcolina
PE20050711A1 (es) 2003-07-17 2005-09-10 Glaxo Group Ltd Compuestos 8-azoniabiciclo[3.2.1] octanos como antagonistas de los receptores muscarinicos de la acetilcolina
NZ546312A (en) 2003-10-14 2008-09-26 Glaxo Group Ltd Muscarinic acetycholine receptor antagonists
AR046225A1 (es) 2003-11-04 2005-11-30 Glaxo Group Ltd Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
US7345060B2 (en) 2003-11-21 2008-03-18 Theravance, Inc. Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
UY28645A1 (es) 2003-12-03 2005-06-30 Glaxo Group Ltd Nuevos antagonistas del receptor muscarinico m3 de acetilcolina
AR046783A1 (es) 2003-12-03 2005-12-21 Glaxo Group Ltd Compuesto de sal ciclica de amonio cuaternario composicion farmaceutica que lo comprende y su uso para preparar esta ultima
JP2007529511A (ja) 2004-03-17 2007-10-25 グラクソ　グループ　リミテッド Ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
WO2005095407A1 (fr) 2004-03-17 2005-10-13 Glaxo Group Limited Antagonistes du recepteur d'acetylcholine muscarinique m3
JP2007529512A (ja) 2004-03-17 2007-10-25 グラクソ　グループ　リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
JP2007529514A (ja) 2004-03-17 2007-10-25 グラクソ　グループ　リミテッド Ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
MY144753A (en) 2004-04-27 2011-10-31 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
WO2005112644A2 (fr) 2004-05-13 2005-12-01 Glaxo Group Limited Antagonistes récepteurs d'acétyle choline muscarinique
TW200606161A (en) 2004-05-28 2006-02-16 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
EP1957075A4 (fr) 2004-11-15 2009-11-18 Glaxo Group Ltd Nouveaux antagonistes des recepteurs muscariniques de type m3 de l'acetylcholine
EP1827439A4 (fr) 2004-11-15 2009-11-18 Glaxo Group Ltd Nouveaux antagonistes du recepteur d'acetylcholine muscarinique m3
PE20061162A1 (es) 2004-12-06 2006-10-14 Smithkline Beecham Corp Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos
PE20060826A1 (es) 2004-12-06 2006-10-08 Smithkline Beecham Corp Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende
WO2006065755A2 (fr) 2004-12-13 2006-06-22 Glaxo Group Limited Sels d'ammonium quaternaire d'amines heteroaromatiques fusionnees utilises comme nouveaux antagonistes du recepteur de l'acetylcholine muscarinique
WO2006065788A2 (fr) 2004-12-13 2006-06-22 Glaxo Group Limited Nouveaux antagonistes du recepteur muscarinique de l'acetylcholine
WO2007018508A1 (fr) 2005-07-28 2007-02-15 Glaxo Group Limited Nouveaux antagonistes du récepteur muscarinique m3 de l’acétylcholine
WO2007018514A1 (fr) 2005-07-28 2007-02-15 Glaxo Group Limited Nouveaux antagonistes récepteurs d’acétylcholine muscarinique m3

Also Published As

Publication number Publication date
EP1677796A2 (fr) 2006-07-12
US7507747B2 (en) 2009-03-24
NO20062071L (no) 2006-05-08
EA200600787A1 (ru) 2006-08-25
CA2542636A1 (fr) 2005-04-28
ZA200602783B (en) 2007-11-28
AP2006003575A0 (en) 2006-04-30
IS8440A (is) 2006-05-05
TW200528448A (en) 2005-09-01
AU2004281167A1 (en) 2005-04-28
WO2005037224A2 (fr) 2005-04-28
AR046114A1 (es) 2005-11-23
JP2007509061A (ja) 2007-04-12
MXPA06004242A (es) 2006-06-28
IL174846A0 (en) 2006-08-20
UY28567A1 (es) 2005-05-31
PE20050442A1 (es) 2005-07-09
ECSP066486A (es) 2006-10-10
US20070135478A1 (en) 2007-06-14
CN1897947A (zh) 2007-01-17
EP1677796A4 (fr) 2006-12-27
WO2005037224A3 (fr) 2005-06-23
OA13270A (en) 2007-01-31
BRPI0415281A (pt) 2006-12-19

Similar Documents

Publication Publication Date Title
MA28110A1 (fr) Antagonistes du recepteur d&#39;acetylcholine muscarinique
MA27900A1 (fr) Antagonistes du recepteur de l&#39;acetylcholine muscarinique
MA27901A1 (fr) Antagonistes du recepteur de l&#39;acetylcholine muscarinique
MA28109A1 (fr) Antagonistes du recepteur acetylcholine muscarinique
MA27973A1 (fr) Antagonistes du recepteur de l&#39;acetylcholine muscarinique
MA28218A1 (fr) Nouveaux antagonistes de recepteur d&#39;acetylcholine muscarinique m3
MA28217A1 (fr) Nouveaux antagonistes de recepteur d&#39;acetylcholine muscarinique m3
CY1118082T1 (el) Ανταγωνιστες μουσκαρινικου υποδοχεα ακετυλοχολινης
TW200600093A (en) M3 muscarinic acetylcholine receptor antagonists
CY1113295T1 (el) Ανταγωνιστες m3 μουσκαρινικου υποδοχεα ακετυλοχολινης
TW200600500A (en) M3 muscarinic acetylcholine receptor antagonists
TW200606161A (en) Muscarinic acetylcholine receptor antagonists
TW200633715A (en) Medical combinations
MA28363A1 (fr) Antagonistes des recepteurs muscariniques de l&#39;acetylcholine
FR2873932B1 (fr) Equipement pour l&#39;apprentissage du putting